Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference
October 25, 2024 08:30 ET
|
Journey Medical Corporation
Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral Doxycycline 40 mg Capsules (Oracea®) in Healthy...